Massachusetts General Hospital

Kaposi's sarcoma treatment in Kenya and Nigeria

  • Principal Investigator(s): Esther Freeman
  • Study Contact: efreeman@mgh.harvard.edu
  • Description of Subjects: Adults with HIV-related Kaposi's sarcoma in Kenya and Nigeria
  • Location (Domestic vs. International): AMPATH (Eldoret, Kenya), Institute of Human Virology (Abuja, Nigeria)
  • Enrollment Period: 2009-2012
  • Enrollment Goal: All KS patients diagnosed at these sites during enrollment period

Uganda AIDS Rural Treatment Outcomes Cohort Study

  • Principal Investigator(s): David Bangsberg, MD
  • Study Contact: Rachel Rifkin617.724.3194rrifkin@partners.org
  • Description of Subjects: All patients over 18 years and initiating ART at the Mbarara Immune Suppression Syndrome Clinic who lived within 60 kilometers from the clinic
  • Location (Domestic vs. International): Mbarara, Uganda

Effect on CNS with ART switch off EFV-based therapy

  • Principal Investigator(s): Nina LIn
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  Effect on CNS with ART switch off EFV-based therapy
  • Location (Domestic vs. International): Domestic, BWH (recruiting can be from MGH or BIDMC)
  • Enrollment Period: Beginning January 2014

HIV and Aging Cohort Study

  • Principal Investigator(s): Nina Lin
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  HIV+ on ART who are </= 35 yo or >/=50yo with no hepatitis co-infection
  • Location (Domestic vs. International): Domestic, BWH, BIDMC, MGH
  • Enrollment Period: 2011-present
  • Enrollment Goal: